ESC Premium Access

Excess risk of heart failure among persons with type 2 diabetes

Topic: Diabetes, dysglycaemia and metabolic syndrome

Presentation

About the speaker

Professor Annika Rosengren

University of Gothenburg, The Sahlgrenska Academy, Institute of Health and Care Sciences, Gothenburg (Sweden)
3 presentations
0 follower

7 more presentations in this session

Efficacy and safety of didpeptidyl peptidase 4 inhibitors and sodium-glucose linked cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation

Speaker: Doctor H. Yokoi (Fukuoka, JP)

Thumbnail

Histone 3 lysine 27 trimethylation in type 2 diabetes: a novel potential pharmacological target in diabetic foot ulcer treatment

Speaker: Doctor M. Colognesi-Capogrossi (Rome, IT)

Thumbnail

Nephro-protective effects of Dapagliflozin in patients with type 2 diabetes

Speaker: Doctor M. Nakayama (Toda, JP)

Thumbnail

Impact of the presence and treatment status of diabetes on long-term mortality following coronary angiography

Speaker: Doctor B. Zafrir (Haifa, IL)

Thumbnail

Access the full session

Improving diabetes outcomes: beyond glucocentricity

Speakers: Professor A. Rosengren, Doctor G. Savarese, Doctor H. Yokoi, Doctor M. Colognesi-Capogrossi, Doctor M. Nakayama...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk